在小鼠中,CFTR调节器elexacaftor和ivacaftor对神经行为的影响不同
1Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN, 38163, United States.
Acta psychologica
|January 14, 2026
概括
像Trikafta这样的新型囊性纤维化 (CF) 药物可能会引起焦虑和抑郁. 这项研究发现,elexacaftor在小鼠中引起焦虑类行为,而ivacaftor在小鼠中引起抑郁类行为,支持这些心理健康问题.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 最近CFTR调节器疗法的进展改善了CF患者的治疗结果.
- 像Trikafta和Alyftrek这样的组合疗法是重要的治疗里程碑.
- 新出现的报道将Trikafta与某些CF患者的焦虑和抑郁联系起来.
研究的目的:
- 在临床前小鼠模型中研究elexacaftor和ivacaftor的神经行为影响.
- 探索CFTR在中枢神经系统中对心理健康的作用.
主要方法:
- 给小鼠使用了elexacaftor和ivacaftor.
- 评估了类似焦虑和类似抑郁的行为.
- 在像杏仁体和海马体这样的大脑区域确认了Cftr mRNA表达.
主要成果:
- 在小鼠中,Elexacaftor的使用诱导了类似焦虑的行为.
- 在小鼠中,Ivacaftor的使用诱导了类似抑郁的行为.
- 在杏仁体和海马体中检测到CftrmRNA.
结论:
- 临床前发现支持CFTR调节器所报告的精神健康副作用.
- CFTR存在于与情绪调节相关的大脑区域.
- 这些见解可能会指导开发具有更好的神经精神病学特征的CF疗法.
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
20.0K
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.7K
相关概念视频
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
